Literature DB >> 15686262

Kernicterus in sick and preterm infants (1999-2002): a need for an effective preventive approach.

Vinod K Bhutani1, Lois H Johnson, Steven M Shapiro.   

Abstract

Kernicterus in sick and preterm infants is a rarity. Universal availability of phototherapy and concerted clinical efforts to identify, effectively manage and establish clinical guidelines have been instrumental in preventing kernicterus in US intensive care nurseries. However, in sick and preterm infants the absence of precise data on prevalence of bilirubin induced neurologic injury, the lack of proven predictive indices and the absence of evidence-based studies that clearly demonstrate the actual risk of kernicterus. These leave questions regarding the basis for clinical strategies and recommendations for the management of neonatal jaundice in this select population. This article reviews 6 preterm infants selected from the Pilot Kernicterus Registry who had recovered from life-threatening neonatal illnesses, briefly discusses current indices used to ascertain risk, and offers an initial bilirubin level based identification of infants while future directions and studies are conducted to supplement our presently incomplete knowledge for safer clinical practice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15686262     DOI: 10.1053/j.semperi.2004.09.006

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  9 in total

Review 1.  Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates.

Authors:  Praveen Kumar; Deepak Chawla; Ashok Deorari
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction.

Authors:  Ann C Rice; Victoria L Chiou; Sarah B Zuckoff; Steven M Shapiro
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

Review 3.  Apnea in acute bilirubin encephalopathy.

Authors:  Sanjiv B Amin; Vinod K Bhutani; Jon F Watchko
Journal:  Semin Perinatol       Date:  2014-09-17       Impact factor: 3.300

4.  A dose-response model for the conventional phototherapy of the newborn.

Authors:  Nelson Ossamu Osaku; Heitor Silvério Lopes
Journal:  J Clin Monit Comput       Date:  2006-06-10       Impact factor: 2.502

5.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

Review 6.  Bilirubin neurotoxicity in preterm infants: risk and prevention.

Authors:  Vinod K Bhutani; Ronald J Wong
Journal:  J Clin Neonatol       Date:  2013-04

7.  Evaluation of neonatal jaundice in the Makkah region.

Authors:  Abdulaziz Alkhotani; Essam Eldin Mohamed Nour Eldin; Amal Zaghloul; Shakil Mujahid
Journal:  Sci Rep       Date:  2014-04-25       Impact factor: 4.379

8.  Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment.

Authors:  Matteo Dal Ben; Cristina Bottin; Fabrizio Zanconati; Claudio Tiribelli; Silvia Gazzin
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

Review 9.  Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.

Authors:  Abida Islam Pranty; Sara Shumka; James Adjaye
Journal:  Cells       Date:  2022-08-25       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.